BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2026-09-14
• Last 15 days FTD volume: NZ$0.17 M
• Last 3 months FTD volume: NZ$1.57 M
• Last 12 months FTD volume: NZ$8.72 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	NZ$4.54 M	NZ$82.6 M	🇺🇸 USA
GSK plc GSK	NZ$36.52 M	NZ$0.16 B	🇬🇧 UK
Sarepta Therapeutics SRPT	NZ$4.73 M	NZ$23.21 M	🇺🇸 USA
Repligen RGEN	NZ$21.73 M	NZ$53.14 M	🇺🇸 USA
Novavax NVAX	NZ$14.38 M	NZ$58.91 M	🇺🇸 USA
Celldex Therapeutics CLDX	NZ$2.93 M	NZ$12.03 M	🇺🇸 USA
NanoViricides NNVC	NZ$0.1 M	NZ$2.85 M	🇺🇸 USA
Cel-Sci CVM	NZ$0.47 M	NZ$2.28 M	🇺🇸 USA
Emergent BioSolutions EBS	NZ$4.52 M	NZ$6.24 M	🇺🇸 USA